FDA Approves Ibrutinib

Ibrutinib is a prescription medicine used to treat people with: Mantle cell lymphoma (MCL) who have received at least one prior treatment Chronic lymphocytic leukemia (CLL) who have received at least one prior treatment. It is...

Read More